Literature DB >> 21915051

Elevated expression of the interleukin-8 receptors CXCR1 and CXCR2 in peripheral blood cells in obstructive coronary artery disease.

Deborah A Leonard1, Michael E Merhige, Brent A Williams, Robert S Greene.   

Abstract

OBJECTIVES: As accumulation of monocytes and macrophages is a feature of atherosclerotic plaque at all stages, inflammatory gene expression profiling of peripheral blood mononuclear cells may provide a more reliable measure of atherogenesis than systemic inflammatory markers. The aim of this study was to determine whether expression patterns of inflammatory regulators in blood are correlated with severity and progression of coronary artery disease.
METHODS: PCR expression arrays were used to profile mRNA levels of 84 candidate genes in blood from three patients with persistent perfusion defects, three with improved perfusion, and two without perfusion defects as measured by serial PET myocardial perfusion imaging. A case-control study compared expression of inflammatory genes in 25 patients with stress-induced perfusion defects and 25 controls using quantitative real-time PCR.
RESULTS: Expression array analysis identified IL-8, CXCR1, and CXCR2 as genes showing increased expression in patients with persistent perfusion defects. The case-control study confirmed a significant increase in CXCR1 (P=0.04) and CXCR2 (P=0.002) mRNAs in blood in males with obstructive CAD, but not in females. There was no difference in IL-8 mRNA level between cases and controls (P=0.1). Coordinated expression of CXCR1 and CXCR2 mRNA was more pronounced in controls (r=0.96) than in patients with perfusion defects (r=0.73).
CONCLUSIONS: mRNA levels for CXCR1 and CXCR2 are increased in blood in males with obstructive CAD and decreased in patients with improved perfusion, suggesting that these genes may serve as markers of disease severity and progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21915051     DOI: 10.1097/MCA.0b013e32834b67e2

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  7 in total

1.  Understanding gene expression in coronary artery disease through global profiling, network analysis and independent validation of key candidate genes.

Authors:  Prathima Arvind; Shanker Jayashree; Srikarthika Jambunathan; Jiny Nair; Vijay V Kakkar
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

2.  The shared crosstalk of multiple pathways involved in the inflammation between rheumatoid arthritis and coronary artery disease based on a digital gene expression profile.

Authors:  Xuyan Niu; Cheng Lu; Cheng Xiao; Zhiguo Zhang; Miao Jiang; Dan He; Yanqin Bian; Ge Zhang; Zhaoxiang Bian; Aiping Lu
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

3.  Impact of Time Delay in Processing Blood Sample on Next Generation Sequencing for Transcriptome Analysis.

Authors:  Jae-Eun Lee; So-Young Jung; So-Youn Shin; Young-Youl Kim
Journal:  Osong Public Health Res Perspect       Date:  2018-06

4.  Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation.

Authors:  Kerstin Pohl; David P Nichols; Jennifer L Taylor-Cousar; Milene T Saavedra; Matthew J Strand; Jerry A Nick; Preston E Bratcher
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

5.  Genetic Variants of CD40 Gene Are Associated with Coronary Artery Disease and Blood Lipid Levels.

Authors:  Liting Zhou; Lin Xie; Dongchun Zheng; Na Li; Jian Zhu; Shuyue Wang; Bo Li; Lin Ye
Journal:  Biomed Res Int       Date:  2016-04-20       Impact factor: 3.411

6.  Analysis of region specific gene expression patterns in the heart and systemic responses after experimental myocardial ischemia.

Authors:  Matthias Zimmermann; Lucian Beer; Robert Ullrich; Dominika Lukovic; Elisabeth Simader; Denise Traxler; Tanja Wagner; Lucas Nemec; Lukas Altenburger; Andreas Zuckermann; Mariann Gyöngyösi; Hendrik Jan Ankersmit; Michael Mildner
Journal:  Oncotarget       Date:  2017-05-17

7.  Serum exosomal miR-328, miR-575, miR-134 and miR-671-5p as potential biomarkers for the diagnosis of Kawasaki disease and the prediction of therapeutic outcomes of intravenous immunoglobulin therapy.

Authors:  Xiaofei Zhang; Guangda Xin; Dajun Sun
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.